{"version":"1.0","provider_name":"Trade Brains Features","provider_url":"https:\/\/tradebrains.in\/features","author_name":"PTI News","author_url":"https:\/\/tradebrains.in\/features\/author\/ptinews\/","title":"Centre's TDB, Sapigen Biologix ink deal to make intranasal COVID-19 vaccine & malaria drug","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"vQC84NbkE2\"><a href=\"https:\/\/tradebrains.in\/features\/biz-sapigen-vaccine\/\">Centre&#8217;s TDB, Sapigen Biologix ink deal to make intranasal COVID-19 vaccine &#038; malaria drug<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/tradebrains.in\/features\/biz-sapigen-vaccine\/embed\/#?secret=vQC84NbkE2\" width=\"600\" height=\"338\" title=\"&#8220;Centre&#8217;s TDB, Sapigen Biologix ink deal to make intranasal COVID-19 vaccine &#038; malaria drug&#8221; &#8212; Trade Brains Features\" data-secret=\"vQC84NbkE2\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","description":"Hyderabad, Mar 26 (PTI) The Technology Development Board (TDB) of the Union Ministry of Science and Technology and Sapigen Biologix Private Limited, Hyderabad on Saturday entered into an agreement for development and commercialisation of two novel vaccines &#8212; &#8220;Intranasal COVID-19 Vaccine and RTS, S Malaria Vaccine&#8221;. Sapigen Biologix is helmed by Krishna Ella of Bharat [&hellip;]"}